Kayle LEOGRANDE was suspended for 2 years by the U.S. Anti-Doping Agency, until 30 November 2010, after a former team doctor declared that Leogrande had admitted to her the use of doping products in July 2007. He committed a second Anti-Doping Rule Violation when testing positive for Raloxifene, Ostarine, Ibutamoren, GW1516 sulfone, RAD140, LGD4033 and Andarine on 30 April 2017 in the Dana Point Grand Prix. He was suspended by the USADA for 8 years, until 24 May 2025.